Related Experiment Video
Updated: Jul 10, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Beta blocker eye drops related airway obstruction
Objective:
To assess the awareness among chest physicians, ophthalmologists and patients about use of eye drops with particular reference to beta blockers such as timolol as an agent of aggravating breathlessness in predisposed subjects.
Design:
Cross-sectional study.
Method:
A survey of 20 chest physicians, 20 ophthalmologists and 200 patients suffering from obstructive airway disease was conducted in 2 hospitals and a welfare center of Karachi from August to September 1997.
Results:
The results indicate that ophthalmologists showed more awareness than chest physicians regarding use of beta blocker eye drops by patients with obstructive airways disease (p = 0.004). Patient awareness was low as well.
Conclusion:
There is a need to update doctors and educate general public about the side effects of beta blocker eye drops in patients with obstructive airway disease.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Antihypertensive Drugs: Types of β-Blockers
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...

